Tag: patent rules in india

Patient advocacy groups have expressed concerns over the draft Patents (Amendment) Rules 2023. They said the changes undermine public health safeguards, including features like pre-grant opposition, working of patents, etc. The draft was released late last month by the Department for Promotion of Industry and Internal Trade for comments from stakeholders. According to advocacy groups, the above features played a key role in two benchmark patent cases involving Novartis blood cancer drug Glivec and Bayer’s kidney cancer drug Nexavar. “The (proposed) amendments introduce a dynamic and exorbitant fee...